Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
6.49%Capital Expenditures Margin
VS
Market
Sector
Industry
History
$ 9.47Close
$ 3.99 - $ 45.62 52-Week Range
Ticker Information
Ticker
ALGSCompany Name
ALIGOS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQALIGOS THERAPEUTICS INC - Capital Expenditures Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ALGS - CapEx % Historical data
| Date | Capital Expenditure | Capital Expenditures Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 206K | 6.49% | $ 3.17M |
| 3/31/2025 | $ 104K | 3.18% | $ 3.27M |
| 12/31/2024 | $ 130K | 3.3% | $ 3.94M |
| 9/30/2024 | $ 109K | 1.82% | $ 6M |
| 6/30/2024 | $ 102K | 1.28% | $ 7.97M |
| 3/31/2024 | $ 81K | 0.59% | $ 13.79M |
| 12/31/2023 | $ 19K | 0.12% | $ 15.53M |
| 9/30/2023 | $ 103K | 0.63% | $ 16.39M |
| 6/30/2023 | $ 87K | 0.5% | $ 17.25M |
| 3/31/2023 | $ 435K | 3.09% | $ 14.06M |
Key Performance Insights, Last 5 Years
- ALIGOS THERAPEUTICS INC's latest trailing twelve months (TTM) CapEx % stands at 0%.
- Over the past 5 years, ALIGOS THERAPEUTICS INC's average CapEx % has been 8.47%.
- The median CapEx % for ALIGOS THERAPEUTICS INC during this period was 3.3%
- ALIGOS THERAPEUTICS INC reached its highest CapEx % over the past 5 years at 35.19%.
- The lowest CapEx % recorded by ALIGOS THERAPEUTICS INC in the same timeframe 0.12%
ALIGOS THERAPEUTICS INC's CapEx % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx % Benchmarks
Similar metrics to Revenues:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].CapEx / Revenues
(=) CapEx % CapEx % for ALIGOS THERAPEUTICS INC is calculated as follows: CapEx [ $ 2.06M ] / Revenues [ $ 0 ]
(=) CapEx % [ 0% ] ALGS - Capital Expenditures Margin, Last 5 years
0.12%
Minimum
Dec 31, 2023
35.19%
Maximum
Jun 30, 2021
8.47%
Average
3.3%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.47% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.85K |
|---|---|
| min | 0% |
| max | 15.02% |
| average | 3.47% |
| median | 2.43% |
| std | 3.27% |